Steven Krozer
Psychiatric/Mental Health · Greenville, SCNPI 1073060737
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Johnson & Johnson accounts for 81.8% of it on its own, with 33 other manufacturers making up the rest. 2025 is the largest year on record at $49,499, 2.4 times the $20,360 reported in 2021. Among psychiatric/mental health clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 871 payments — averaging $159.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$114K
- Janssen Scientific Affairs, LLC$10K
- AbbVie$4K
- Neurocrine Biosciences, Inc.$2K
- E.r. Squibb & Sons, L.L.C.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- plus $7K from 28 others
What the payments were for
- Consulting fees$26,66419%
- Speaking & faculty fees$70,31050%
- Travel & lodging$25,75718%
- Food & beverage$16,44812%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 251 | $113,953 |
| Janssen Scientific Affairs, LLC | 16 | $9,542 |
| AbbVie | 160 | $4,036 |
| Neurocrine Biosciences, Inc. | 26 | $2,210 |
| E.r. Squibb & Sons, L.L.C. | 10 | $1,235 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 54 | $1,103 |
| Otsuka America Pharmaceutical, Inc. | 58 | $959 |
| Alkermes, Inc. | 26 | $790 |
| Takeda Pharmaceuticals U.S.A., Inc. | 50 | $730 |
| Axsome Therapeutics, Inc. | 27 | $661 |
| Sunovion Pharmaceuticals Inc. | 28 | $536 |
| Vanda Pharmaceuticals Inc. | 21 | $442 |
| Supernus Pharmaceuticals, Inc. | 22 | $433 |
| Lundbeck LLC | 26 | $431 |
| Teva Pharmaceuticals USA, Inc. | 16 | $275 |
| Avanir Pharmaceuticals, Inc. | 11 | $275 |
| Acadia Pharmaceuticals Inc | 8 | $257 |
| Bausch Health US, LLC | 13 | $230 |
| Livanova USA, Inc. | 1 | $198 |
| Tris Pharma Inc | 8 | $152 |
| Ironshore Pharmaceuticals Inc. | 5 | $134 |
| Almatica Pharma LLC | 8 | $131 |
| Biogen | 2 | $104 |
| Corium, LLC | 4 | $67 |
| Boehringer Ingelheim | 1 | $64 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $46 |
| Merck | 3 | $45 |
| Eisai Inc. | 3 | $43 |
| Noven Therapeutics, LLC | 2 | $40 |
| Gilead | 2 | $32 |
| Neos Therapeutics, LP | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Neuronetics, Inc. | 2 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$110,448
- INVEGA$2,285
- INVEGA TRINZA$1,688
- INVEGA SUSTENNA$1,249
- VRAYLAR$257
- VNS Therapy Symmetry Model 8103 Generator$198
- INGREZZA$124
- NUEDEXTA$122
- NUPLAZID$116
- QELBREE$104
- Auvelity$101
How this compares
$139,238 in reported general payments places this provider in the 95th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 26 | $41,446 |
| NuedextaDextromethorphan Hbr/Quinidine | 13 | $20,788 |
| LybalviOlanzapine/Samidorphan Malate | 12 | $19,034 |
| VraylarCariprazine Hcl | 14 | $18,770 |
| DayvigoLemborexant | 12 | $3,807 |
| Lurasidone Hcl | 38 | $2,412 |
| Quetiapine Fumarate | 85 | $930 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 25 | $921 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 32 | $891 |
| Hydroxyzine Hcl | 58 | $871 |
| Ramelteon | 11 | $827 |
| Bupropion XlBupropion Hcl | 70 | $785 |
| Lamotrigine | 103 | $702 |
| Clonazepam | 106 | $543 |
| Divalproex Sodium ErDivalproex Sodium | 23 | $543 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,103 | $41,44626 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $275 | $20,78813 claims |
| Alkermes, Inc.Lybalvi | $790 | $19,03412 claims |
| AbbVieVraylar | $4,036 | $18,77014 claims |
| Eisai Inc.Dayvigo | $43 | $3,80712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 354 psychiatric/mental health providers in South Carolina.
Other psychiatric/mental health in Greenville
- Luron FlemingGreenville$61K
- Lauren DyerGreenville$16K
- Melissa BrownGreenville$16K
- William HendricksGreenville$13K
- Carrie BallengerGreenville$11K
- Gregory SmithGreenville$9K
- Svetlana RobinsonGreenville$8K
- Jared CarboneGreenville$7K
- Anglique RichGreenville$6K
- Matthew HendricksGreenville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.